ASHEVILLE, N.C. – September 14, 2016 – Peter Sagonias knew he was at risk for prostate cancer. The retired pharmacist lost his father after a short battle with the disease.
“He was gone just three months after he was diagnosed. So from that moment on, I knew I had to be vigilant about my own health,” said Sagonias.
He went for regular prostate checks, as well as Prostate-Specific Antigen (PSA) tests. For years, those exams came back normal, until one day in 2002.
“My PSA spiked which was very unusual. Given my father’s history, my doctor wanted to take a closer look. That’s when he found the tumor.”
A biopsy was scheduled, and twelve cores were taken from the prostate to determine if it was malignant. All twelve came back positive. The 62-year-old had prostate cancer.
Sagonias was referred to Bruce Armstrong, M.D. at Asheville Urological Associates, a division of 21st Century Oncology.
“We scheduled surgery within a month of Mr. Sagonias’ diagnosis, and were able to completely remove the cancer. He was very fortunate in catching it early. It hadn’t spread, and that was the extent of the treatment he needed,” said Dr. Armstrong.
Fourteen years later, Mr. Sagonias is still cancer-free, and he has a message for other men during September’s Prostate Cancer Awareness Month.
“Take care of your own health. It’s not pleasant going in for prostate checks, but you have to do it, or pay the price. There’s no doubt in my mind that I wouldn’t be here today if I hadn’t stayed vigilant. I would have missed out on the last 14 years with my family and friends. Nothing can replace that.”
For more information about our services, visit www.ashevilleurological.com or call (828) 253-5314.
About 21st Century Oncology:
21st Century Oncology is the largest global, physician led provider of Integrated Cancer Care services. The company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of December 31, 2015, the Company operated 181 treatment centers, including 145 centers located in 17 U.S. states and 36 centers located in seven countries in Latin America. The company holds market-leading positions in most of its domestic local markets and abroad.